Connection

Adrian Hernandez to Antibodies, Monoclonal

Back to Details
This is a "connection" page, showing publications Adrian Hernandez has written about Antibodies, Monoclonal.
Adrian Hernandez
Connection Strength
0.022
Antibodies, Monoclonal
  1. Safety and Efficacy of PD-1/PD-L1 Inhibitors in Treatment-Naive and Chemotherapy-Refractory Patients With Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis. Clin Lung Cancer. 2018 05; 19(3):e335-e348.
    View in: PubMed
    Score: 0.011
  2. Incidence of Pneumonitis With Use of Programmed Death 1 and Programmed Death-Ligand 1 Inhibitors in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis of Trials. Chest. 2017 08; 152(2):271-281.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.